Safety and efficacy of ledipasvir/sofosbuvir in a genotype 1 HCV infected chinese population: Results from a phase 3, clinical trial | |
Wei L., Xie Q., Hou J., Tang H., Ning Q., Cheng J., Nan Y., Zhang L., Li J., Jiang J., McNabb B.L., Zhang F., Camus G., Mo H., McNally J., Brainard D.M., Subramanian M., Gong G., Mou Z., Wu S., Wang Q | |
刊名 | Hepatology
![]() |
2017 | |
ISSN号 | 1527-3350 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3538636 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Wei L., Xie Q., Hou J., Tang H., Ning Q., Cheng J., Nan Y., Zhang L., Li J., Jiang J., McNabb B.L., Zhang F., Camus G., Mo H., McNally J., Brainard D.M., Subramanian M., Gong G., Mou Z., Wu S., Wang Q. Safety and efficacy of ledipasvir/sofosbuvir in a genotype 1 HCV infected chinese population: Results from a phase 3, clinical trial[J]. Hepatology,2017. |
APA | Wei L., Xie Q., Hou J., Tang H., Ning Q., Cheng J., Nan Y., Zhang L., Li J., Jiang J., McNabb B.L., Zhang F., Camus G., Mo H., McNally J., Brainard D.M., Subramanian M., Gong G., Mou Z., Wu S., Wang Q.(2017).Safety and efficacy of ledipasvir/sofosbuvir in a genotype 1 HCV infected chinese population: Results from a phase 3, clinical trial.Hepatology. |
MLA | Wei L., Xie Q., Hou J., Tang H., Ning Q., Cheng J., Nan Y., Zhang L., Li J., Jiang J., McNabb B.L., Zhang F., Camus G., Mo H., McNally J., Brainard D.M., Subramanian M., Gong G., Mou Z., Wu S., Wang Q."Safety and efficacy of ledipasvir/sofosbuvir in a genotype 1 HCV infected chinese population: Results from a phase 3, clinical trial".Hepatology (2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论